KISIMA-02 vaccine-based immunotherapy for patients with pancreatic cancer

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2022-501854-12-01

Acronym

KISIMA-02

Enrollment

Registered

2024-04-04

Start date

2025-02-05

Completion date

Unknown

Last updated

2025-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G12D/G12V Pancreatic Ductal Adenocarcinoma

None listed

Sex/Gender

All

Age

18 Years to No maximum

France, Germany, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026